IndusInd Bank On Track To Improve Liability Franchise, Asset Quality, Says Macquarie
IndusInd Bank Ltd. expects slippages to normalise in the next one or two quarters, according to Macquarie. The bank is showing improvement on the net interest margin front in the quality of the liability franchise, it said after meeting with the lender's management.
The management expects the liquidity pressure that is hampering resource mobilisation to ease after a rate cut that is expected in the second half of the next fiscal. This, in turn, will help narrow the gap between loan and deposit growth, the brokerage said.
The management also noted that, "given the strong credit demand in vehicle finance and microfinance, it expects its loan portfolio to grow 1.5 times the industry growth".
Macquarie has maintained an 'outperform' rating on the lender with a price target of Rs 1,449 apiece. "We believe the shares look cheap given the ROA trajectory," Macquarie said.
Asset Quality To Normalise
The bank saw higher than expected slippage than it guided for in the past two quarters due to slippage in microfinance, vehicle finance, LAP, agriculture, merchant banking and two corporate accounts, Macquarie said.
However, the management expects these slippages to normalise, and it said that it will create contingent buffers to strengthen the balance sheet while making sure profitability is maintained.
Outlook For Liability Franchise
Going forward, as retail deposits rise, the management expects to reduce the term deposit rate gap between the bank and its peers.
"The near-term focus is to reduce the share of the top 20 depositors, and the medium-term target is to improve the retail deposit mix to 50% from the current 45%," the report said, citing the management.
The company's management expects to improve it by increasing market share in home markets to 5% from the current 3.7%–3.8%, focusing on NRIs and affluent segments, focusing on select communities, and expanding branches.
In addition to this, the management also expects final approval from the RBI to allow promoters to increase their stake and operating leverage to play out in the medium term once investments in technology reduce.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
